• Home
  • News
  • Portfolio News
  • Platelet BioGenesis Appoints Biotech Industry Veteran Sam Rasty, Ph.D., as President and Chief Executive Officer

Platelet BioGenesis Appoints Biotech Industry Veteran Sam Rasty, Ph.D., as President and Chief Executive Officer

02Jul

Platelet BioGenesis Appoints Biotech Industry Veteran Sam Rasty, Ph.D., as President and Chief Executive Officer

Portfolio News
Platelet BioGenesis (PBG), the leader in stem cell-derived, on-demand human platelets (PLTs+™) and platelet-based therapeutics, announced today the hiring of Sam Rasty, Ph.D., as President and CEO. Read more >>

Share this post

Related Posts

22Jun

A New Wave of Dating Apps Takes Cues From TikTok and Gen Z

Online dating exploded in popularity during the pandemic, and the number of new startups has grown. But will they last?... read more
05Sep

Rapid Lyme disease test may be available in late 2020

The drawn-out process for diagnosing Lyme disease could become a thing of the past – good news for the thousands... read more
27Jun

Wasabi Debuts U.S. West Coast New Data Center in Hillsboro, Oregon

Opens New Hot Cloud Storage Opportunities For US West Coast and Pac Rim Companies While Providing Direct Connection to One... read more
14Jun

Myomo, Inc. Launches MyoPro® 2

Myomo, Inc., a commercial stage medical robotics company, today announced the launch of its next-generation MyoPro® myoelectric arm orthosis (powered... read more
29Jun

David Friend Interviews WBZ Radio

A day after the latest ransomware hit computers and corporations around the world, some companies are still trying to recover. David Friend the... read more
20Jun

Secrets are hard to keep — but these 3 tech founders still chose stealth mode

Wasabi provides “hot storage,” which means it’s fast to write, low-cost and reliable cloud storage. Read more >> read more
19Oct

San Antonio researchers developing brain injury treatment

Research that began in San Antonio could soon produce a first-of-its-kind treatment for traumatic brain injuries, like concussions and strokes.... read more
27Aug

XYLYX BIO releases highly physiologic 2D substrates for improved antifibrotic drug discovery

New York-based Xylyx Bio, a leader in advanced disease models, today announced the release of normal and fibrotic NativeCoat™ human... read more
23Oct

ZetrOZ Receives Funding from the National Institute of Health to Find New Ways to Reduce Arthritic Pain for Over 60 Million Americans Using Non-Narcotic, Non-Surgical Technology

ZetrOZ Systems, developers of sustained acoustic medicine (SAM), an FDA-cleared home-use ultrasound device that helps reduce pain associated with tendon,... read more
11Jan

Bone adhesive dev Launchpad Medical raises $9m | Medtech Funding Roundup

Launchpad Medical has raised $8.5 million in a new round of equity financing, according to recently posted SEC filings. Read... read more